The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial
Beijing Xisike Clinical Oncology Research Foundation
National Natural Science Foundation of China
Peking University
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article
The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial
Xueyan Cheng, Shanyuan Zhang, Yuzhao Wang, Enli Zhang et al.
Journal
BMC Medicine
Topics
Lung Cancer Research Studies
article
The role of dynamic monitoring of plasma cell-free DNA methylation in predicting pathological response in resectable stage IIB-IIIB non-small cell lung cancer: biomarker analyses from a prospective phase II trial
Xueyan Cheng, Shanyuan Zhang, Yuzhao Wang, Enli Zhang, Yu S. Huang, Tao Wei, Xinrui Cui, Shaolei Li, Li‐Di Xu, Bateer Han, Minglei Zhuo, Ye Tao, Chao Lv, Xiang Li, Bing Liu, Nan Wu, Yan Shi, Miao Huang, Z. Xie, Xuantong Zhou, Weizhi Chen, Yuge Zhu, Yaqi Wang, Jia Wang
article en
Abstract
No abstract available for this paper.
Publication Tag
BMC MedicineVol. 23(1)
Institutions
Peking University (CN), Peking University Cancer Hospital (CN), Ministry of Education (ET), Genecast (China) (CN), Inner Mongolia Medical University (CN)
Funders
Beijing Xisike Clinical Oncology Research Foundation, National Natural Science Foundation of China, Peking University